U.S. Markets close in 5 hrs 27 mins
  • S&P 500

    +8.27 (+0.21%)
  • Dow 30

    +33.83 (+0.10%)
  • Nasdaq

    +30.56 (+0.26%)
  • Russell 2000

    -5.80 (-0.33%)
  • Crude Oil

    -0.45 (-0.65%)
  • Gold

    +6.50 (+0.33%)
  • Silver

    +0.20 (+0.91%)

    +0.0016 (+0.1510%)
  • 10-Yr Bond

    +0.0110 (+0.31%)
  • Vix

    -0.83 (-3.88%)

    +0.0021 (+0.1738%)

    +0.1730 (+0.1306%)

    +579.13 (+2.08%)
  • CMC Crypto 200

    +3.36 (+0.54%)
  • FTSE 100

    +34.04 (+0.45%)
  • Nikkei 225

    +520.94 (+1.93%)

Harbinger Research Provides Updated Research Report on NaturalShrimp, Inc. With a Strong Speculative Buy Rating and a 12 to 24-month Price Target of $2.16 Per Share

NEW YORK, NY / ACCESSWIRE / April 19, 2018 / Harbinger Research, LLC, an equity research boutique based in New York, NY recently announced updated research coverage of NaturalShrimp, Inc. (SHMP) with a Strong Speculative Buy, and a 12 to 24 month price target of $2.16 per share.

Senior Research Analyst, Brian Connell, CFA, said, "The Company's patent-pending technology is potentially disruptive to the entire shrimp farming industry, which, on a global basis, produced $39 billion worth of shrimp in 2017. Vibrio Suppression Technology simultaneously eliminates almost all water-borne bacteria and viruses while also keeping ammonia at safe concentrations."

Mr. Connell goes on to state that "According to the Company, NaturalShrimp's disruptive water technology causes ammonia (NH3) to break down into harmless nitrogen and hydrogen gas, thus eliminating one of the historically most difficult problems in shrimp aquaculture."

"The potential to commercially scale this solution represents an immense competitive advantage for NaturalShrimp."

"Assuming a near-term capital infusion, the Company should begin scaling up production to serve the San Antonio, Las Vegas and New York City markets in CY2018."

Gerald Easterling, NaturalShrimp's president said, "We are very pleased to have updated research coverage provided by a firm such as Harbinger Research."

"We believe our patent-pending, Vibrio Suppression Technology will revolutionize the indoor, closed-system shrimp aquaculture industry, and we are looking forward to having Harbinger, and firms like it, help keep the investment community up to date regarding our progress."

The research report is available here: NaturalShrimp, Inc. Closed-System Shrimp Farming Research Report prepared by Brian R. Connell CFA for Harbinger Research

About Harbinger Research, LLC

Harbinger Research is an independent equity research firm focused on providing coverage to small-cap companies. Our mission is to help clients achieve fairer market valuations, expanded shareholder bases, improved liquidity and easier access to capital markets. We do this by providing insightful, in-depth research reports that are widely distributed and made available to both institutional and individual investors.

To view our research reports, visit www.harbingerresearch.com.

About NaturalShrimp, Inc.

NaturalShrimp, Inc. is a publicly traded agro-tech company headquartered in Dallas, TX with production facilities located near San Antonio. The Company has developed and tested the first commercially viable system for growing shrimp indoors using patent-pending, proprietary technologies that produce fresh, never-frozen, naturally grown shrimp without the use of antibiotics or toxic chemicals.

For more information please visit www.naturalshrimp.com.

Safe Harbor Act: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter forward-looking statements, whether as a result of new information, future events or otherwise.



SOURCE: Harbinger Research, LLC